You are here

Clinical Trials: Heart Attack

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, February 13, 2018 - 12:00
Conditions:   Hypoplastic Left Heart Syndrome;   Heart Defects, Congenital;   Pediatric Disorder
Intervention:   Biological: Autologous Human Placental Cord Blood Mononuclear Cells
Sponsor:   Murdoch Childrens Research Institute
Recruiting
Posted: Thursday, February 1, 2018 - 12:00
Condition:   Heart Failure
Interventions:   Drug: CardioCell;   Drug: Placebos
Sponsors:   John Paul II Hospital, Krakow;   KCRI;   National Center for Research and Development, Poland
Not yet recruiting
Posted: Friday, January 19, 2018 - 12:00
Condition:   Myocardial Infarction
Interventions:   Drug: Cardiac Drug;   Drug: Placebos
Sponsors:   John Paul II Hospital, Krakow;   KCRI;   National Center for Research and Development, Poland
Recruiting
Posted: Thursday, January 11, 2018 - 12:00
Condition:   Ischemic Cardiomyopathy
Interventions:   Combination Product: CSWT+BMMSCs;   Device: CSWT+Sham operation
Sponsor:   Shanghai 10th People's Hospital
Not yet recruiting
Posted: Wednesday, November 22, 2017 - 12:00
Conditions:   Chronic Heart Failure;   Old Myocardial Infarction
Intervention:   Biological: Stem cells administered to participants
Sponsors:   Sakakibara Heart Institute;   CellBank of Japan
Not yet recruiting
Posted: Friday, October 13, 2017 - 12:00
Condition:   Cardiovascular Diseases
Interventions:   Behavioral: Health360x;   Behavioral: Health Coach
Sponsors:   Emory University;   American Heart Association
Recruiting
Posted: Tuesday, July 4, 2017 - 12:00
Conditions:   Coronary Heart Disease;   Angina Pectoris;   Myocardial Infarction
Interventions:   Device: COMBO;   Device: ORSIRO
Sponsors:   Aarhus University Hospital Skejby;   Biotronik SE & Co. KG;   OrbusNeich
Recruiting - verified July 2017
Posted: Tuesday, May 2, 2017 - 12:00
Conditions:   Myocardial Infarction;   Heart Failure
Interventions:   Biological: Intracoronary injection of stem cell;   Biological: Placebo
Sponsor:   SCARM Institute, Tabriz, Iran
Not yet recruiting - verified July 2017
Posted: Tuesday, February 7, 2017 - 12:00
Conditions:   Myocardial Infarction;   Stem Cell Transplantation;   Angioplasty, Transluminal, Percutaneous Coronary
Interventions:   Drug: Atorvastatin;   Drug: Intensive Atorvastatin;   Drug: Low dose BMMSC;   Drug: Middle dose BMMSC;   Drug: High dose BMMSC;   Drug: Transplantation
Sponsors:   Yuejin Yang;   Peking Union Medical College Hospital;   The First Hospital of Hebei Medical University;   Zunyi Medical College
Not yet recruiting - verified February 2017
Posted: Monday, September 26, 2016 - 12:00
Condition:   Ebstein Anomaly
Interventions:   Biological: Autologous Bone Marrow-derived Mononuclear Cells;   Device: Insertable cardiac monitor
Sponsor:   Timothy J. Nelson
Recruiting

Pages